血清NFL可区分帕金森病与非典型帕金森综合征
研究纳入临床有明确帕金森综合征表现但诊断未定的患者,随访3年(最长12年)确立帕金森病(PD,n=55)与非典型帕金森综合征(APD,n=29)诊断。血清NFL在APD组(均值23.8±10.3 ng/L)显著高于PD组(10.4±4.9 ng/L)与对照(11.5±6.5 ng/L,p<0.0001),鉴别准确率最高达91%(敏感度86%、特异度85%)。
要点
- 血清NFL在APD组明显高于PD组和对照组,p<0.0001。
- 血清NFL鉴别APD与PD的准确率最高达91%,敏感度86%、特异度85%。
- 本队列中APD的阳性预测值为76%,PD的阴性预测值为92%。
核心结论
- 血清NFL在APD中较PD显著升高,能以较高准确率区分APD与PD。
- 血清NFL或可作为识别APD的临床生物标志物,即便在临床症状尚不明确阶段。
- 该研究提供Class II证据支持血清NFL准确区分APD与PD。
研究设计与样本
- 纳入临床有明确帕金森综合征表现但入组时诊断未定的患者,采集血清样本。
- 随访3年确立PD与APD诊断,若有更长随访数据则最长更新至12年。
- 采用单分子阵列技术定量血清NFL,PD组55例、APD组29例(多系统萎缩22例、进行性核上性麻痹7例)、非神经科对照53例。
主要发现
- 血清NFL在APD组均值23.8±10.3 ng/L,高于PD组10.4±4.9 ng/L与对照11.5±6.5 ng/L,p<0.0001。
- 血清NFL区分APD的准确率最高达91%,敏感度86%、特异度85%。
- 血清NFL与脑脊液NFL在所有组中强相关(r=0.72,p<0.0001)。
- 血清NFL与年龄在PD组(r=0.78,p<0.0001)和对照组(r=0.66,p<0.0001)相关。
- 本队列中APD的阳性预测值为76%,PD的阴性预测值为92%。
临床怎么用
- 对临床有帕金森综合征表现但具体诊断未定的患者,可检测血清NFL辅助区分APD与PD。
- 血清NFL升高更支持APD,有助于在临床症状尚不典型时提示APD可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the diagnostic value of serum neurofilament light chain (NFL) in patients with clear signs of parkinsonism but whose specific diagnosis was yet uncertain. METHODS: Serum samples were collected from patients with clear signs of parkinsonism but with uncertain diagnosis at the inclusion. Clinical diagnoses of Parkinson disease (PD) and atypical parkinsonism disorders (APDs) were established after 3 years of follow-up and updated again after a maximum of 12 years in case longer follow-up data were available. Serum NFL was quantified by single molecule array in patients with PD (n = 55) and APD (n = 29, multiple system atrophy = 22, progressive supranuclear palsy = 7) and 53 nonneurologic controls. RESULTS: Serum NFL levels were elevated and differentiated the APD group (mean 23.8 ± 10.3 ng/L) from PD (mean 10.4 ± 4.9 ng/L) and controls (mean 11.5 ± 6.5 ng/L, p < 0.0001) with accuracy levels up to 91% (sensitivity = 86% and specificity = 85%). Serum NFL strongly correlated with CSF NFL levels (r = 0.72, p < 0.0001) in all groups and with age in PD (r = 0.78, p < 0.0001) and controls (r = 0.66, p < 0.0001). In our cohort, the probability of having APD was 76% (positive predictive value) and of having PD 92% (negative predictive value). CONCLUSION: Serum NFL levels are markedly elevated in APD compared to PD and discriminate APDs from PD with high accuracy. Serum NFL may be a useful clinical biomarker to identify APD, even at stages when clinical symptoms are not yet conclusive. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that serum NFL levels accurately discriminate APDs from PD.
引用
- Marques TM, van Rumund A, Oeckl P, et al. Serum NFL discriminates Parkinson disease from atypical parkinsonisms. Neurology. 2019. PMID: 30814322. doi:10.1212/WNL.0000000000007179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。